These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 35116381

  • 1. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database.
    Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X.
    Transl Cancer Res; 2021 Dec; 10(12):5337-5351. PubMed ID: 35116381
    [Abstract] [Full Text] [Related]

  • 2. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
    Shan L, Lu Y, Xiang CC, Zhu X, Zuo ED, Cheng X.
    J Immunol Res; 2022 Dec; 2022():2547029. PubMed ID: 35571565
    [Abstract] [Full Text] [Related]

  • 3. Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas.
    Shan L, Lu Y, Song Y, Zhu X, Xiang CC, Zuo ED, Cheng X.
    Oxid Med Cell Longev; 2022 Dec; 2022():9529814. PubMed ID: 35910847
    [Abstract] [Full Text] [Related]

  • 4. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K, Wang F, Li K, Peng G, Yang H, Xu H, Xiang Y, Sun H.
    Technol Cancer Res Treat; 2022 Dec; 21():15330338221085354. PubMed ID: 35422168
    [Abstract] [Full Text] [Related]

  • 5. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.
    Wang Y, Li N, Tian D, Zhou CW, Wang YH, Yang C, Zeng MS.
    Cancer Manag Res; 2021 Dec; 13():6451-6471. PubMed ID: 34429653
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of m6A-related lncRNAs for prognostic and immunotherapeutic response in hepatocellular carcinoma.
    Wu X, Wang S, Wu X, Chen Q, Cheng J, Qi Z.
    J Cancer; 2024 Dec; 15(7):2045-2065. PubMed ID: 38434979
    [Abstract] [Full Text] [Related]

  • 8. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L, Xie R, Lu G.
    Biosci Rep; 2021 Jun 25; 41(6):. PubMed ID: 34027555
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J, Lin X, Zhuang J, He F.
    Front Genet; 2021 Jun 25; 12():714697. PubMed ID: 34777460
    [Abstract] [Full Text] [Related]

  • 13. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W, Ren J, Yuan W, Xiang R, Ge Y, Fu T.
    Genes (Basel); 2021 Aug 31; 12(9):. PubMed ID: 34573357
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS.
    BMC Cancer; 2022 Mar 24; 22(1):316. PubMed ID: 35331183
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
    Fang Q, Chen H.
    Mol Med; 2020 Jun 17; 26(1):60. PubMed ID: 32552682
    [Abstract] [Full Text] [Related]

  • 20. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J, Mao W, Sun S, Hu Q, Wang C, Xu Z, Liu R, Chen S, Xu B, Chen M.
    Front Oncol; 2021 Jun 17; 11():663263. PubMed ID: 34123820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.